Aug. 9 at 12:46 PM
$MNKD Here's why hype and exuberance around Mannkind's progress will likely propel MNKD to over
$50/sh by the end of 2028...
APPROVALS {and eventual accretive} ADDS TO MNKD SHARE PRICE [B4 EOY 2028]:
+
$4 -- acquisition of scPharma [
$SCPH ]
+
$4 -- label change - Afrezza
+
$1 -- Afrezza in India
+
$6 -- pediatric Afrezza
+
$8 -- FDA approved Furoscix auto injector
+
$2 -- gestational Afrezza
+
$6 -- Ralinepag DPI [MNKD-1501
$UTHR ]
+
$8 -- Nintedanib DPI [MNKD-201]
+
$3 -- Bumetanide DPI [MNKD-701]
+
$6 -- Tyvaso DPI bridge for IPF & PPF
+ $? -- Undisclosed drug
--------
+
$48/sh
Take a š š«µ
$SPY and
$QQQ š¤
